These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23603779)

  • 21. "Blind" vaginal fetal fibronectin as a predictor of spontaneous preterm delivery.
    Roman AS; Koklanaris N; Paidas MJ; Mulholland J; Levitz M; Rebarber A
    Obstet Gynecol; 2005 Feb; 105(2):285-9. PubMed ID: 15684153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal fibronectin detection in preterm labor: evaluation of a prototype bedside dipstick technique and cervical assessment.
    Coleman MA; McCowan LM; Pattison NS; Mitchell M
    Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1553-8. PubMed ID: 9855595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid fetal fibronectin swab-test in preterm labor patients treated by betamimetics.
    Benattar C; Taieb J; Fernandez H; Lindendaum A; Frydman R; Ville Y
    Eur J Obstet Gynecol Reprod Biol; 1997 Apr; 72(2):131-5. PubMed ID: 9134390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labour as a predictor of delivery before 34 weeks' gestation.
    Parker J; Bell R; Brennecke S
    Aust N Z J Obstet Gynaecol; 1995 Aug; 35(3):257-61. PubMed ID: 8546638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal fibronectin: the impact of a rapid test on the treatment of women with preterm labor symptoms.
    Plaut MM; Smith W; Kennedy K
    Am J Obstet Gynecol; 2003 Jun; 188(6):1588-93; discussion 1593-5. PubMed ID: 12824997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of fetal fibronectin as a predictor of preterm delivery in high risk asymptomatic pregnancies.
    Leeson SC; Maresh MJ; Martindale EA; Mahmood T; Muotune A; Hawkes N; Baldwin KJ
    Br J Obstet Gynaecol; 1996 Jan; 103(1):48-53. PubMed ID: 8608098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal fibronectin status and cervical length in women with threatened preterm labor and the effectiveness of maintenance tocolysis.
    Roos C; Vis JY; Scheepers HC; Bloemenkamp KW; Duvekot HJ; van Eyck J; de Groot C; Kok JH; Opmeer BC; Oudijk MA; Papatsonis DN; Porath MM; Sollie K; Spaanderman ME; Lotgering FK; van der Post JA; Mol BW
    J Matern Fetal Neonatal Med; 2016; 29(10):1556-61. PubMed ID: 26103778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rational use of fetal fibronectin in the evaluation of premature labor risk].
    Rozenberg P; Nisand I; Malagrida L; Vayssière C; Goffinet F; Philippe HJ; Tribalat S; Giudicelli Y
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):288-93. PubMed ID: 8767228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fetal fibronectin and cervical length as early predictors of preterm labor].
    López Farfán JA; Sánchez Tovar HB; Gutiérrez de Anda Mdel R; Gámez Guevara C
    Ginecol Obstet Mex; 2011 Jun; 79(6):337-43. PubMed ID: 21966824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of cervicovaginal fetal fibronectin status to guide treatment of threatened preterm labour.
    Watson DL; Kim SJ; Humphrey MD
    Aust N Z J Obstet Gynaecol; 1998 May; 38(2):185-7. PubMed ID: 9653857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evaluation of maternal systemic thiol/disulphide homeostasis for the short-term prediction of preterm birth in women with threatened preterm labour: a pilot study.
    Cetin O; Karaman E; Alisik M; Erel O; Kolusari A; Sahin HG
    J Obstet Gynaecol; 2022 Aug; 42(6):1972-1977. PubMed ID: 35648800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test.
    Ting HS; Chin PS; Yeo GS; Kwek K
    Ann Acad Med Singap; 2007 Jun; 36(6):399-402. PubMed ID: 17597963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM; Fox NS; Chasen ST
    J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of fetal fibronectin as a predictor of preterm delivery for a low-risk population.
    Greenhagen JB; Van Wagoner J; Dudley D; Hunter C; Mitchell M; Logsdon V; Casal D; Varner M
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):1054-6. PubMed ID: 8885775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery.
    Morrison JC; Allbert JR; McLaughlin BN; Whitworth NS; Roberts WE; Martin RW
    Am J Obstet Gynecol; 1993 Feb; 168(2):538-42. PubMed ID: 8438924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal fibronectin for evaluation of preterm labor in the setting of cervical cerclage.
    Benson JE; Landy HJ; Ghidini A; Drassinower D; Poggi SH
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2330-2. PubMed ID: 22694302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of fetal fibronectin testing in minimising hospital admissions, length of hospital stay and cost savings in women presenting with symptoms of pre-term labour.
    Dutta D; Norman JE
    J Obstet Gynaecol; 2010; 30(8):768-73. PubMed ID: 21126111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Identification the risk of preterm labor :the role of fetal fibronectin].
    Karamisheva V; Ivanov S; Nikolov A; Jordanova D; Dimitrov G; Nachev A
    Akush Ginekol (Sofiia); 2015; 54(1):3-6. PubMed ID: 25909122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting preterm delivery: the fetal fibronectin test.
    Leeson S; Maresh MJ
    Prof Care Mother Child; 1994 Mar; 4(2):38-9. PubMed ID: 8680158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized comparison of nifedipine and placebo in fibronectin-negative women with symptoms of preterm labor and a short cervix (APOSTEL-I Trial).
    Vis JY; van Baaren GJ; Wilms FF; Oudijk MA; Kwee A; Porath MM; Scheepers HC; Spaanderman ME; Bloemenkamp KW; van Lith JM; Bolte AC; Bax CJ; Cornette J; Duvekot JJ; Nij Bijvank SW; van Eyck J; Franssen MT; Sollie KM; Woiski M; Vandenbussche FP; van der Post JA; Bossuyt PM; Opmeer BC; Mol BW
    Am J Perinatol; 2015 Apr; 32(5):451-60. PubMed ID: 25486290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.